TOMPKINS FINANCIAL CORP
TMPAbout the company
Tompkins Financial Corporation, a financial holding company, provides commercial and consumer banking, leasing, trust and investment management, financial planning and wealth management, and insurance services. It operates through two segments: Banking, and Wealth Management. The company accepts various deposit products, including checking and savings accounts, time deposits, and IRA products.
Investment snapshot
Positive
5
BUY / PASS
Neutral / negative
7 / 4
NEUTRAL / FAIL
Median fair value
$88.81
-11.5% vs price
Models with upside
4 / 16
Positive margin of safety
Strongest signal
6 of 8 pass — Ackman and Sleep object
Key risk
Split decision: 7 NEUTRAL · 4 FAIL · 3 PASS · 2 BUY
Framework analysis
| Verdict | Meaning |
|---|---|
| BUY | Positive purchase signal: the framework's buy requirements are met. |
| PASS | The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state. |
| NEUTRAL | Neither a positive nor negative conclusion. It does not mean to hold an existing position. |
| FAIL | The company does not clear the framework's requirements. |
| Ranked | Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL. |
Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.
| Metric | Graham Defensive Value | Buffett Quality Compounder | Lynch GARP | Piotroski F-Score | Dreman Contrarian Value | Munger Quality Focus | Pabrai Dhandho Framework | Akre Three-Legged Stool | Marks Risk-Aware Value | Ackman Activist Value | Templeton Global Bargain Hunter | Sleep Scale Economies Shared | Asness Systematic Factors | Neff Low-P/E Total Return | Schloss Asset-Value Discipline | O'Shaughnessy Systematic Factor Composite |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verdict | FAIL | FAIL | BUY | NEUTRAL | NEUTRAL | BUY | NEUTRAL | PASS | NEUTRAL | FAIL | NEUTRAL | PASS | NEUTRAL | PASS | NEUTRAL | FAIL |
| Score | ||||||||||||||||
| Analysis | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… |
| Intrinsic Value (annual) | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||||
| Margin of Safety | +21.8% | +39.9% | +46.4% | N/A | -19.0% | -218.0% | -7.6% | +33.1% | -28.5% | -244.7% | -192.8% | N/A | N/A | N/A | N/A | N/A |
| Financial Basis | Annual history · FY 2025 Latest source filing: 2026-02-26 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-02-26 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-09-30 vs 2025-09-30 · TTM ended 2026-09-30 Latest source filing: 2026-10-30 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-02-26 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-09-30 · Market data at 2026-11-01 Latest source filing: 2026-10-30 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 · TTM ended 2026-09-30 Latest source filing: 2026-10-30 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 Latest source filing: 2026-02-26 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment · TTM ended 2026-09-30 Latest source filing: 2026-10-30 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-02-26 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-09-30 · Market data at 2026-11-01 Latest source filing: 2026-10-30 Score computed: 2026-11-14 | Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 · Balance sheet at 2026-09-30 Latest source filing: 2026-10-30 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-02-26 Score computed: 2026-11-14 | TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2025 Latest source filing: 2026-10-30 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-09-30 Latest source filing: 2026-10-30 Score computed: 2026-11-14 | Annual history · FY 2025 · Balance sheet at 2026-09-30 Latest source filing: 2026-10-30 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-09-30 · Price history 2025-01-01–2026-11-01 Latest source filing: 2026-10-30 Score computed: 2026-11-14 |
Where It Passes
- Growth75% pass✓ 9✗ 3▾
6 of 8 pass — Ackman and Sleep object
EPS Growth (3-yr avg, 10-yr window)108.0%✓Graham>= 33% growthBasic earnings-growth PEG (dividends excluded)0.54✓Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR16.7%✓Lynch15-30% (Fast Grower); > 0% to passEPS Growth Direction$2.56 (2004) -> $11.24 (2025)✓DremanPositive over recent yearsEPS CAGR7.3% CAGR over 21 years✓Dreman> 5% annualizedPositive Net Income Frequency21/21 years positive✓MarksPositive net income in >= 7 of last 10 years3yr Median Revenue Growth1.4%✗Ackman>= 5%Positive EPS Growth Frequency3/5 years with positive EPS growth✓AckmanPositive EPS growth in >= 3 of last 5 years5-Year EPS CAGR16.7% CAGR over 5 years✓Templeton> 0% (5-year EPS CAGR)Revenue growth vs. gross and operating margin trend✗SleepRevenue rising; gross margin flat or falling; operating margin holding5-year Revenue CAGR2.9%✗SleepCAGR > 7%3-5 Year Diluted EPS CAGR16.7% over 5 years✓Neff7%-20% annualized - Efficiency67% pass✓ 2✗ 1▾
2 of 3 pass — Piotroski objects
Revenue / Total Assets Change YoY0.01x -> 0.01x✗PiotroskiImproved YoYReinvestment Rate x ROIC15.1% (RR=79% x ROIC=19.3%)✓AkreReinvestment Rate * ROIC > 10%ROE (5-year)3/5 years above 12% (latest 17.2%)✓SleepROE > 12% in a majority of years - Verdicts56% pass✓ 5✗ 4▾
Split decision: 7 NEUTRAL · 4 FAIL · 3 PASS · 2 BUY
Overall verdict✗GrahamFAIL (2/7)✗BuffettFAIL (1/6)✓LynchBUY (3/4)•PiotroskiNEUTRAL (F-Score 5)•DremanNEUTRAL (6/9)✓MungerBUY (3/3)•PabraiNEUTRAL (2/3)✓AkrePASS (2/5)•MarksNEUTRAL (3/4)✗AckmanFAIL (3/8)•TempletonNEUTRAL (5/8)✓SleepPASS (3/6)•AsnessNEUTRAL (Not ranked)✓NeffPASS (6/6)•SchlossNEUTRAL (4/7)✗OshaughnessyFAIL (Rank #352/963 (Top 36.6%))
Where It Falls Short
- Valuation33% pass✓ 11✗ 15▾
8 of 12 flag TMP's valuation — Graham, Dreman, Marks +5 more
Price / 3-yr avg EPS17.9x✗Graham<= 15xPrice-to-Tangible-Book Ratio1.7x✗Graham<= 1.5xP/E x P/TBV29.80✗Graham<= 22.5Basic earnings-growth PEG (dividends excluded)0.54✓Lynch< 1.0 (ideally < 0.5)Price / EPS8.9x✓Dreman< 12x✓Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)Price / (CFO / Shares)37.1x✗Dreman< 8xPrice / Tangible Book Value per Share1.7x✗Dreman< 1.2x✗SchlossP/TBV <= 1.00x (app cutoff)Valuation ReasonablenessP/E=8.9x, OE Yield=11.1%✓MungerP/E < 25 or Owner Earnings Yield > 5%P/E or FCF YieldP/E=8.9x, FCF Yield=2.2%✓PabraiP/E < 15 or FCF Yield > 10%P/B or P/E vs. Historical AverageP/E=8.9x, P/B=1.5x✓MarksP/E < 15 or P/B < 2.0Discount to Intrinsic Value-19.0% (IV=$84.35 vs Price=$100.39)✗Marks>= 20% below intrinsic valuePrice / FCF per Share45.2x✗Ackman<= 25Price vs. Trailing Low168% of trailing low ($59.60)✗Templeton<= 120% of trailing low (certified split-adjusted live window)Price / Book Value per Share1.5x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)Net income / market capitalization+12.51%; #474/6340 (top 7.5%)✓AsnessTop 30% of eligible cross-section✓OshaughnessyTop 10% of eligible cross-sectionPositive book equity / market capitalization+0.6500; #2360/6449 (top 36.6%)✗AsnessTop 30% of eligible cross-sectionPrice / Diluted EPS8.9x✓NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)(EPS CAGR % + Dividend Yield %) / P/E2.15✓Neff> 0.7 (Neff's published traditional edge)Book Value per Share Change+35.8%✓SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)Revenue / market capitalization+0.0526; #4561/5247 (top 86.9%)✗OshaughnessyTop 10% of eligible cross-section(Operating cash flow - capex) / market capitalization+3.45%; #1937/4519 (top 42.9%)✗OshaughnessyTop 10% of eligible cross-sectionTrailing six-month price return through the evaluation date+19.13%; #1383/6202 (top 22.3%)✗OshaughnessyTop 10% of eligible cross-section - Valuation models40% pass✓ 4✗ 6▾
Models split on TMP at $100.39 — fair values range $29.13–$187.35
Graham fair value$128.46✓Graham+21.8% margin vs $100.39Buffett fair value$167.10✓Buffett+39.9% margin vs $100.39Lynch fair value$187.35✓Lynch+46.4% margin vs $100.39Dreman fair value$84.35✗Dreman-19.0% margin vs $100.39Munger fair value$31.57✗Munger-218.0% margin vs $100.39Pabrai fair value$93.28✗Pabrai-7.6% margin vs $100.39Akre fair value$150.11✓Akre+33.1% margin vs $100.39Marks fair value$78.11✗Marks-28.5% margin vs $100.39Ackman fair value$29.13✗Ackman-244.7% margin vs $100.39Templeton fair value$34.29✗Templeton-192.8% margin vs $100.39 - Profitability44% pass✓ 21✗ 14▾
9 of 16 flag TMP's profitability — Graham, Buffett, Piotroski +6 more
Return on Equity19.3%✓Munger> 15%✗AkreROE > 20% (3-year avg)Positive EPS (10 years)21/22 years positive✗GrahamPositive EPS every year for 10 yearsEPS Growth (3-yr avg, 10-yr window)108.0%✓Graham>= 33% growthNet Income Positive (10+ years)21/22 years positive✗BuffettPositive every year for 10+ yearsROE (up to 5-year arithmetic mean)10.9%✗Buffett> 15% arithmetic mean (app rule)Operating Margin (10-yr trend)✗BuffettStable or rising over 10 yearsFree Cash Flow Proxy$160.8M✓BuffettPositive and growingEarnings Variance (10-yr CoV)0.51✗BuffettCoV < 0.3Retained Earnings Effectiveness✗Buffett$1 retained -> > $1 market value createdBasic earnings-growth PEG (dividends excluded)0.54✓Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR16.7%✓Lynch15-30% (Fast Grower); > 0% to passROE19.3%✓Lynch> 15%Net Income / Total Assets1.86%✓PiotroskiROA > 0ROA Change YoY0.87% -> 1.86% (delta: +0.98%)✓PiotroskiCurrent ROA > Prior ROA(CFO / Total Assets) vs ROACFO/Assets=0.45%, ROA=1.86%✗PiotroskiCFO/Assets > ROAPre-Tax Income / Revenue296.9%✓Dreman>= 8%Net Income / Shareholders' Equity19.3%✓Dreman> 12%Margin of SafetyP/E=8.9x, P/TBV=1.7x✓PabraiP/TBV < 1.5 or P/E < 15ROE (high and growing)FY2023: ROE=1.4%; FY2024: ROE=9.9%; FY2025: ROE=17.2%✗AkreLatest 3 consecutive FYs: ROE > 15% in eachDiscount to Intrinsic Value-19.0% (IV=$84.35 vs Price=$100.39)✗Marks>= 20% below intrinsic valuePositive Net Income Frequency21/21 years positive✓MarksPositive net income in >= 7 of last 10 yearsOperating Income / Revenue✗Ackman>= 15%Net Income / Shareholders Equity19.3%✓Ackman>= 15%5-Year EPS CAGR16.7% CAGR over 5 years✓Templeton> 0% (5-year EPS CAGR)Operating Margin Trend✗TempletonNon-negative operating-margin trend over 3 yearsRevenue growth vs. gross and operating margin trend✗SleepRevenue rising; gross margin flat or falling; operating margin holdingROE (5-year)3/5 years above 12% (latest 17.2%)✓SleepROE > 12% in a majority of yearsNet income / market capitalization+12.51%; #474/6340 (top 7.5%)✓AsnessTop 30% of eligible cross-section✓OshaughnessyTop 10% of eligible cross-sectionGross profit / total assets✗AsnessTop 30% of eligible cross-sectionNet income / positive book equity+19.25%; #833/5226 (top 15.9%)✓AsnessTop 30% of eligible cross-sectionNegative 5-year standard deviation of ROA-0.0056; #526/5884 (top 8.9%)✓AsnessTop 30% of eligible cross-section3-5 Year Diluted EPS CAGR16.7% over 5 years✓Neff7%-20% annualizedPositive Diluted-EPS Years10/10 years positive✓Schloss>= 70% positive over 5-10 observed years (app rule) - Debt & Leverage50% pass✓ 3✗ 2▾
2 of 4 pass — Asness and Schloss object
LT Debt / Total Assets Change0.00% -> 0.00%✓PiotroskiDecreased YoYTotal Debt / Shareholders' Equity0.43✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00xNegative debt-to-equity (higher means less debt)-0.4343; #2328/4210 (top 55.3%)✗AsnessTop 30% of eligible cross-sectionCurrent Assets / Current Liabilities✗SchlossCurrent ratio >= 1.50x (app cutoff) - Cash Flow50% pass✓ 6✗ 6▾
5 of 10 pass — Lynch, Piotroski, Dreman +2 more object
Free Cash Flow Proxy$160.8M✓BuffettPositive and growingFCF Positive and Growing$49.8M✗LynchPositive and growingOperating Cash Flow$38.9M✓PiotroskiCFO > 0(CFO / Total Assets) vs ROACFO/Assets=0.45%, ROA=1.86%✗PiotroskiCFO/Assets > ROAPrice / (CFO / Shares)37.1x✗Dreman< 8xP/E or FCF YieldP/E=8.9x, FCF Yield=2.2%✓PabraiP/E < 15 or FCF Yield > 10%FCF Positive17/17 years FCF positive✓MarksPositive FCF in majority of recent years(OCF - CapEx) / Market Cap3.4%✗Ackman>= 4%Price / FCF per Share45.2x✗Ackman<= 25Positive Operating Cash Flow frequency19/19 years positive✓SleepPositive OCF in >= 70% of available yearsOperating Cash Flow - Capital Expenditures$49.8M✓Neff> $0 (app proxy for a strong fundamental case)(Operating cash flow - capex) / market capitalization+3.45%; #1937/4519 (top 42.9%)✗OshaughnessyTop 10% of eligible cross-section
Business & financials
Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.
Company Profile
Financial Snapshot
Leverage is a bank’s business model and current accounts don’t exist on its balance sheet, so debt and liquidity tests are omitted and tangible book value and ROE replace their industrial analogs.
Shareholder Return
Fiscal 2025
Retired 0.0% of shares last year, 0.2% issued over two.
- Buybacks
- $1.6M
- Dividends
- $36.1M
What drove EPS
A buyback raises earnings per share without the company earning more. This splits each year's change into the two.
The two parts do not sum exactly to the total — the difference is the cross-term, plus preferred capital where the company has any. It is left visible rather than distributed into the other two.
Share count is the denominator the filer used for diluted EPS, recovered as net income ÷ EPS — not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.
Company Financials
Latest TTM and quarters alongside annual years
TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.
The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.
| Metric | TTM · 2026-09-30 2025-10-01 – 2026-09-30 Sources · derived quarter valuesDerived from cumulative filings: net income, pre tax income, operating cash flow, capex, dividends paid, buybacks. | Q3 FY 2026 2026-07-01 – 2026-09-30 Sources · derived quarter valuesDerived from cumulative filings: operating cash flow, capex, dividends paid, buybacks. | Q2 FY 2026 2026-04-01 – 2026-06-30 Sources · derived quarter valuesDerived from cumulative filings: operating cash flow, capex, dividends paid, buybacks. | Q1 FY 2026 2026-01-01 – 2026-03-31 Sources | FY 2025Sources
| FY 2024Sources
| FY 2023Sources
| FY 2022Sources
| FY 2021Sources
|
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $1.4Bcurrent | -- | -- | -- | $1.1Best. | $962.1Mest. | $647.3Mest. | $956.5Mest. | $988.0Mest. |
| Revenue | -- | -- | -- | -- | $75.7M↓5% | $79.3M↑6% | $75.0M↑1% | $74.0M↑2% | $72.6M |
| Operating Income | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Income | $180.3M↑113% | $28.7M↑21% | $29.3M↑36% | $26.1M↑32% | $161.1M↑127% | $70.8M↑645% | $9.5M↓89% | $85.0M↓5% | $89.3M |
| EPS (Diluted) | -- | $2.00↑21% | $2.04↑36% | $1.82↑33% | $11.24↑126% | $4.97↑653% | $0.66↓89% | $5.89↓3% | $6.05 |
| Gross Margin | — | — | — | — | — | — | — | — | — |
| Operating Margin | — | — | — | — | — | — | — | — | — |
| ROE | 19.3%↑80% | — | — | — | 17.2%↑73% | 9.9%↑598% | 1.4%↓90% | 13.8%↑13% | 12.3% |
| Total Debt | $406.7M↓9% | $406.7M↓9% | $546.4M↓19% | $449.4M↓9% | $169.4M↓69% | $543.2M↑335% | $125.0M↑150% | $50.0M↓55% | $110.0M |
| Shareholders' Equity | $936.4M↑19% | $936.4M↑19% | $959.9M↑26% | $946.7M↑28% | $938.4M↑32% | $713.4M↑7% | $668.5M↑9% | $616.0M↓15% | $727.5M |
| Current Ratio | — | — | — | — | — | — | — | — | — |
| Debt / Equity | 0.43↓23% | 0.43↓23% | 0.57↓36% | 0.47↓29% | 0.18↓76% | 0.76↑307% | 0.19↑130% | 0.08↓46% | 0.15 |
| Operating Cash Flow | $59.0M↓41% | $37.9M↑9% | -$15.1M↓180% | $73.4M↑230% | $38.9M↓59% | $95.0M↑7% | $89.0M↓14% | $103.3M↓15% | $121.2M |
| Free Cash Flow | $49.8M↓47% | $36.9M↑9% | -$17.1M↓194% | $71.1M↑241% | $31.9M↓64% | $88.8M↑8% | $82.2M↓14% | $95.2M↓18% | $116.4M |
Score history
Historical Score Timeline
Industry peers
Industry Peers
Similar companies in Banking
TMP vs Peers — Financial Grading
| Company | Market Cap | Price | Revenue | Net Income | ROE | D/E | Op. Margin | Curr. Ratio | Graham | Buffett | Lynch | Piotroski | Dreman |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MITSUBISHI UFJ FINANCIAL GROUP INCMUFG | $245.7B | $21.83 | $74.2B | $10.8B | 8.8% | 1.12 | 19.9% | — | 2/7 | 1/6 | 1/4 | F-Score 5 | 3/9 |
| AMERICAN EXPRESS COAXP | $215.0B | $320.60 | $41.3B | $10.8B | 32.4% | 1.68 | — | — | 2/7 | 3/6 | 3/4 | F-Score 4 | 3/9 |
| Banco Santander, S.A.SAN | $175.9B | $12.21 | — | $16.6B | 12.5% | 0.02 | — | — | 2/7 | 1/6 | 2/4 | F-Score 4 | 5/9 |
| BARCLAYS BANK PLCATMP | $82.1B | $35.04 | $13.1B | $6.3B | 7.5% | 0.01 | — | — | 2/7 | 1/6 | 0/4 | F-Score 7 | 4/9 |
| BARCLAYS PLCBCS | $76.0B | $22.87 | $15.0B | $9.7B | 9.2% | 0.02 | — | — | 1/7 | 0/6 | 0/4 | F-Score 7 | 2/9 |
| FIRST CITIZENS BANCSHARES INC /DE/FCNCA | $25.7B | $2324.25 | $9.5B | $2.2B | 9.9% | 1.62 | — | — | 5/7 | 3/6 | 1/4 | F-Score 5 | 2/9 |
| KEYCORP /NEW/KEY | $22.7B | $21.46 | $7.5B | $1.8B | 9.0% | 0.49 | — | — | 2/7 | 1/6 | 1/4 | F-Score 6 | 4/9 |
| WEBSTER FINANCIAL CORPWBS | $12.6B | $77.57 | $2.9B | $1.0B | 10.6% | 0.08 | 50.7% | — | 2/7 | 1/6 | 1/4 | F-Score 7 | 2/9 |